Drug Patent Expirations for Jun 8, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

SPIRIVA RESPIMAT (tiotropium bromide)
Boehringer Ingelheim
Patent number: 6,453,795
Expiration Date: Jun 5, 2017

NUCYNTA (tapentadol hydrochloride)
Depomed Inc
Patent number: 6,071,970
Expiration Date: Jun 6, 2017

NUCYNTA ER (tapentadol hydrochloride)
Depomed Inc
Patent number: 6,071,970
Expiration Date: Jun 6, 2017

RAZADYNE (galantamine hydrobromide)
Janssen Pharms
Patent number: 6,358,527
Expiration Date: Jun 6, 2017

RAZADYNE (galantamine hydrobromide)
Janssen Pharms
Patent number: 6,099,863
Expiration Date: Jun 6, 2017

PROTONIX (pantoprazole sodium)
Wyeth Pharms Inc
Patent number: 5,997,903
Expiration Date: Jun 7, 2017

BRISDELLE (paroxetine mesylate)
Sebela Ireland Ltd
Patent number: 5,874,447
Expiration Date: Jun 10, 2017

VICOPROFEN (hydrocodone bitartrate; ibuprofen)
Abbvie
Patent number: 6,599,531
Expiration Date: Jun 10, 2017

VICOPROFEN (hydrocodone bitartrate; ibuprofen)
Abbvie
Patent number: 6,348,216
Expiration Date: Jun 10, 2017

GABITRIL (tiagabine hydrochloride)
Cephalon
Patent number: 5,958,951
Expiration Date: Jun 10, 2017

PEXEVA (paroxetine mesylate)
Sebela Ireland Ltd
Patent number: 5,874,447
Expiration Date: Jun 10, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


This post was originally published on this site
Comments are closed.